BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 22005546)

  • 1. Mesothelioma and small cell lung cancer.
    Tsao AS; Heymach J
    J Thorac Oncol; 2011 Nov; 6(11 Suppl 4):S1825-6. PubMed ID: 22005546
    [No Abstract]   [Full Text] [Related]  

  • 2. ERCC1 and small cell lung cancer.
    Rossi G; Nannini N; Tiseo M
    J Thorac Oncol; 2010 Nov; 5(11):1876-7. PubMed ID: 20975385
    [No Abstract]   [Full Text] [Related]  

  • 3. Summary of presentations from the 11th targeted therapies for lung cancer meeting: radiation oncology.
    Iyengar P; Choy H
    J Thorac Oncol; 2011 Nov; 6(11 Suppl 4):S1822-4. PubMed ID: 22005545
    [No Abstract]   [Full Text] [Related]  

  • 4. Immune checkpoint inhibition in malignant mesothelioma: Does it have a future?
    Mansfield AS
    Lung Cancer; 2017 Mar; 105():49-51. PubMed ID: 28089229
    [No Abstract]   [Full Text] [Related]  

  • 5. Excision repair cross-complementing-1 for small cell lung cancer.
    Kim YH; Ishii G; Ochiai A
    J Thorac Oncol; 2011 Mar; 6(3):652; author reply 652. PubMed ID: 21317752
    [No Abstract]   [Full Text] [Related]  

  • 6. Genomic profiling of small-cell lung cancer: the era of targeted therapies.
    Umemura S; Tsuchihara K; Goto K
    Jpn J Clin Oncol; 2015 Jun; 45(6):513-9. PubMed ID: 25670763
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 2015 American Society of Clinical Oncology annual meeting.
    Cleghorn S
    Lancet Respir Med; 2015 Jul; 3(7):516-7. PubMed ID: 26078097
    [No Abstract]   [Full Text] [Related]  

  • 8. Targeted therapies for small cell lung cancer: Where do we stand?
    Arcaro A
    Crit Rev Oncol Hematol; 2015 Aug; 95(2):154-64. PubMed ID: 25800975
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of SMARCAL1 as a molecular target for small cell lung cancer treatment.
    Jiang Y; Li S; Ramesh R
    Cancer Lett; 2024 Jun; 592():216932. PubMed ID: 38735383
    [No Abstract]   [Full Text] [Related]  

  • 10. Targeting hypoxia in the treatment of small cell lung cancer.
    Bryant JL; Meredith SL; Williams KJ; White A
    Lung Cancer; 2014 Nov; 86(2):126-32. PubMed ID: 25201720
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Systemic issues in small cell lung cancer.
    Lopez-Chavez A; Sandler A
    Curr Probl Cancer; 2012; 36(3):131-55. PubMed ID: 22633107
    [No Abstract]   [Full Text] [Related]  

  • 12. Summary of presentations from the 46th Annual Meeting of the American Society of Clinical Oncology (2010) focus on tumor biology and biomarkers related to lung cancer.
    Subramanian J; Corrales L; Soulieres D; Morgensztern D; Govindan R
    J Thorac Oncol; 2011 Feb; 6(2):399-403. PubMed ID: 21206384
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A tabulated summary of targeted and biologic therapies for non-small-cell lung cancer.
    Somaiah N; Simon NG; Simon GR
    J Thorac Oncol; 2012 Dec; 7(16 Suppl 5):S342-68. PubMed ID: 23160320
    [No Abstract]   [Full Text] [Related]  

  • 14. Pemetrexed: current development and future directions in thoracic cancers.
    Manegold C
    Suppl Tumori; 2002; 1(4):S11-2. PubMed ID: 12415805
    [No Abstract]   [Full Text] [Related]  

  • 15. Targeted therapy in small cell lung cancer: A new era?
    Capelletto E; Mariniello A; Novello S
    Lung Cancer; 2017 Jun; 108():252-253. PubMed ID: 28343730
    [No Abstract]   [Full Text] [Related]  

  • 16. Review on clinical trials of targeted treatments in malignant mesothelioma.
    Jakobsen JN; Sørensen JB
    Cancer Chemother Pharmacol; 2011 Jul; 68(1):1-15. PubMed ID: 21553148
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Emerging drugs for small cell lung cancer--an update.
    Metro G; Duranti S; Fischer MJ; Cappuzzo F; Crinò L
    Expert Opin Emerg Drugs; 2012 Mar; 17(1):31-6. PubMed ID: 22288522
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Malignant Mesothelioma: Time to Translate?
    Napolitano A; Carbone M
    Trends Cancer; 2016 Sep; 2(9):467-474. PubMed ID: 28603777
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Beyond chemotherapy: Emerging biomarkers and therapies as small cell lung cancer enters the immune checkpoint era.
    Della Corte CM; Gay CM; Byers LA
    Cancer; 2019 Feb; 125(4):496-498. PubMed ID: 30620399
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Eve of the third millennium, providing an update on the management of non-small cell lung cancer (NSCLC).
    Le Chevalier T
    Anticancer Drugs; 2001 Jul; 12 Suppl 3():S1. PubMed ID: 11556248
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.